RUMORED BUZZ ON NEUROPSYCHOLOGICAL TEST BATTERY FOR DEMENTIA

Because people who carry the APOE e4 gene variant surface to have a bigger risk of great troubles, the FDA recommends being tested for that gene variant before beginning treatment with lecanemab or donanemab.All subjects finished a list of NAB tests as Section of a more complete, single-session neuropsychological test protocol, which includes These